tiprankstipranks
Advertisement
Advertisement

GH Stock Latest News

Guardant Health announces U.S. FDA approved Guardant360 Liquid CDx
The FlyGuardant Health announces U.S. FDA approved Guardant360 Liquid CDx
6d ago
GH
Guardant Health price target raised to $135 from $130 at Piper Sandler
PremiumThe Fly
Guardant Health price target raised to $135 from $130 at Piper Sandler
14d ago
GH
Guardant Health Earnings Call Highlights Breakout Growth
PremiumCompany Announcements
Guardant Health Earnings Call Highlights Breakout Growth
17d ago
GH
Guardant Health price target raised to $95 from $90 at Evercore ISI
PremiumThe Fly
Guardant Health price target raised to $95 from $90 at Evercore ISI
17d ago
GH
Guardant Health price target raised to $129 from $120 at Baird
PremiumThe Fly
Guardant Health price target raised to $129 from $120 at Baird
17d ago
GH
Guardant Health price target raised to $135 from $130 at JPMorgan
PremiumThe FlyGuardant Health price target raised to $135 from $130 at JPMorgan
18d ago
GH
Guardant Health price target raised to $120 from $115 at Barclays
Premium
The Fly
Guardant Health price target raised to $120 from $115 at Barclays
18d ago
GH
Guardant Health reports Q1 adjusted EPS (45c), consensus (47c)
Premium
The Fly
Guardant Health reports Q1 adjusted EPS (45c), consensus (47c)
18d ago
GH
Guardant Health raises FY26 revenue view to $1.3B-$1.32B from $1.25B-$1.28B
PremiumThe Fly
Guardant Health raises FY26 revenue view to $1.3B-$1.32B from $1.25B-$1.28B
18d ago
GH
Guardant Health receives FDA approval for Guardant360 CDx
PremiumThe Fly
Guardant Health receives FDA approval for Guardant360 CDx
22d ago
GH
PFE
Guardant falls after FDA panel votes down AstraZeneca breast cancer drug
PremiumThe Fly
Guardant falls after FDA panel votes down AstraZeneca breast cancer drug
25d ago
GH
AZN
Guardant Health announces multi-year strategic collaboration with Nuvalent
PremiumThe Fly
Guardant Health announces multi-year strategic collaboration with Nuvalent
25d ago
GH
NUVL
Guardant Health: Buy Rating Reiterated as Management Changes Seen as Non-Disruptive and $135 Price Target Maintained on Multiple Growth Catalysts
PremiumRatingsGuardant Health: Buy Rating Reiterated as Management Changes Seen as Non-Disruptive and $135 Price Target Maintained on Multiple Growth Catalysts
27d ago
GH
Overhang should lift for Guardant after AstraZeneca AdCom, says Leerink
Premium
The Fly
Overhang should lift for Guardant after AstraZeneca AdCom, says Leerink
27d ago
GH
AZN
Guardant falls after FDA briefing documents for camizestrant
Premium
The Fly
Guardant falls after FDA briefing documents for camizestrant
27d ago
GH
AZN
Guardant Health Announces Resignation of Chief Medical Officer
PremiumCompany Announcements
Guardant Health Announces Resignation of Chief Medical Officer
28d ago
8K
GH
Guardant Health Chief Medical Officer resigns effective May 8
PremiumThe Fly
Guardant Health Chief Medical Officer resigns effective May 8
28d ago
GH
Guardant Health: Near-Term Catalysts Underscore Strengthening Long-Term Growth Outlook
PremiumRatings
Guardant Health: Near-Term Catalysts Underscore Strengthening Long-Term Growth Outlook
1M ago
GH
Guardant Health price target lowered to $115 from $130 at Barclays
PremiumThe Fly
Guardant Health price target lowered to $115 from $130 at Barclays
1M ago
GH
Oscar, Guardant, Redwire, Gap, AFLAC: Insider Moves Shock Wall Street
PremiumWeekend UpdatesOscar, Guardant, Redwire, Gap, AFLAC: Insider Moves Shock Wall Street
1M ago
GH
AFL
William Blair health diagnostics analyst holds analyst/industry conference call
Premium
The Fly
William Blair health diagnostics analyst holds analyst/industry conference call
2M ago
GH
ABT
Citi adds ‘upside 90-day catalyst watch’ on Guardant Health
Premium
The Fly
Citi adds ‘upside 90-day catalyst watch’ on Guardant Health
2M ago
GH

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >